1. Abstract 15704: Morbidity and Mortality After Anatomic Repair of Congenitally Corrected Transposition of the Great Arteries: Understanding Risks for Patient and Family Counseling
- Author
-
Ray Lowery, Tiffany R Lim, Megan Wilde, Kimberly J Watkins, Richard G. Ohye, Katherine Afton, Michael Gaies, Sunkyung Yu, Andrew Rodenbarger, Rebecca R Hartog, and Caren S. Goldberg
- Subjects
Family therapy ,medicine.medical_specialty ,Congenitally corrected transposition ,business.industry ,Great arteries ,Physiology (medical) ,medicine ,Cardiology and Cardiovascular Medicine ,business ,Surgery - Abstract
Introduction: Anatomic repair of congenitally corrected transposition of the great arteries (ccTGA) generally poses short-term risk for presumed long-term functional benefit by restoring the left ventricle to the systemic circulation. Understanding early and late surgical outcomes is crucial for counseling patients and families. Methods: All patients with anatomic repair at a single institution from 1993-2018 were included. Follow-up data was obtained by contact with patients’ primary cardiologists. The primary outcome was long-term survival and the secondary outcome was freedom from reintervention. Univariate Cox proportional hazard model was used to identify risk factors for mortality. In-hospital mortality and morbidity were compared between the most recent (2010-2018) and past surgical eras. Results: Anatomic repair was performed in 118 patients: 64 Senning/arterial switch operations (ASO) and 54 Senning/Rastelli operations. Survival was 85%, 82%, and 70% at 1, 10, and 20 years after repair, respectively, and was significantly lower in the Senning/Rastelli group compared to Senning/ASO (Hazard ratio 3.0, p=0.01; Figure 1). Preoperative factors associated with mortality were heterotaxy syndrome (p=0.03) and right ventricular systolic dysfunction (p=0.01). During a median follow up of 9.4 years, 47 of 98 patients (48%) required surgical or catheter-based reintervention; median freedom from reintervention was 11.7 years. For the most recent era, 30 of 32 patients (94%) with Senning/ASO and 19 of 22 patients (86%) with Senning/Rastelli operations survived to hospital discharge. In-hospital morbidity was similar between eras (30% in 1993-2009 and 28% in 2010-2018, p=0.82). Conclusions: Short- and long-term outcomes are favorable following Senning/ASO. Mortality following Senning/Rastelli operations remains high, highlighting the need for careful patient selection and family counseling.
- Published
- 2020
- Full Text
- View/download PDF